AJP - Endocrinology and Metabolism, Vol 270, Issue 4 E572-E579, Copyright © 1996 by American Physiological Society

ARTICLES

Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function

M. M. Byrne, J. Sturis, R. J. Sobel and K. S. Polonsky
Department of Medicine, Pritzker School of Medicine, University of Chicago, Illinois 60637, USA.

Studies were performed in subjects with no known family history of diabetes, normoglycemic subjects who have first-degree relatives with non-insulin-dependent diabetes mellitus (NIDDM), and subjects with nondiagnostic oral glucose tolerance tests (NDX) or impaired glucose tolerance (IGT). Insulin sensitivity index (SI) was similar in all four groups. However, a number of defects in insulin secretion were seen in the NDX and IGT groups, including reduced first-phase insulin secretory responses in intravenous glucose in relation to the degree of insulin resistance, and reduced normalized spectral power of insulin secretion during oscillatory glucose infusion. The latter finding demonstrates a decreased ability of the beta-cell to detect and respond to the successive increases and decreases in glucose and therefore to be entrained by the exogenous glucose infusion. The ability of a low-dose glucose infusion to prime the insulin secretory response to a subsequent glucose stimulus was normal in subjects with IGT but reduced or absent in subjects with overt NIDDM. These studies demonstrate that a number of alterations in beta-cell function are detectable in nondiabetic first-degree relatives of subjects with NIDDM with mild elevations in the 2-h postchallenge glucose level, and these abnormalities antedate the onset of overt hyperglycemia and clinical diabetes.

This article has been cited by other articles:

				A. Mari, A. Gastaldelli, A. Natali, T. Ostergard, O. Schmitz, and E. Ferrannini Characterization of {beta}-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E541 - E546. [Abstract] [Full Text] [PDF]

				C. Simon and G. Brandenberger Ultradian Oscillations of Insulin Secretion in Humans Diabetes, February 1, 2002; 51(90001): S258 - 261. [Abstract] [Full Text] [PDF]

				A. Brandt, M. Katschinski, R. Arnold, K. S. Polonsky, B. Goke, and M. M. Byrne GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E242 - E247. [Abstract] [Full Text] [PDF]

				G. Toffolo, E. Breda, M. K. Cavaghan, D. A. Ehrmann, K. S. Polonsky, and C. Cobelli Quantitative indexes of {beta}-cell function during graded up&down glucose infusion from C-peptide minimal models Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E2 - E10. [Abstract] [Full Text] [PDF]

				J. Meyer, J. Sturis, M. Katschinski, R. Arnold, B. Goke, and M. M. Byrne Acute hyperglycemia alters the ability of the normal beta -cell to sense and respond to glucose Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E917 - E922. [Abstract] [Full Text] [PDF]